Skip to main content

Table 1 Patient demographics and baseline characteristics (n = 83)

From: Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Patient characteristics N %
Median age (range) 68 (31–93)
Sex
 - male 47 57
 - female 36 43
ECOG
 - 0 49 59
 - 1 24 29
 - 2 10 12
Stage
 - IV 62 75
 - III inoperable 21 25
Adjuvant chemotherapy 8 9.6
Stage III n = 21 100%
Chemoradiation for locally advanced disease 7 33.3
Stage IV n = 62 100%
Metastatic sites at start of first palliative CHT
 - Liver 40 64.5
 - Lung 15 24.2
 - Peritoneum 14 22.6
 - Bone 3 4.8
 - Other 4 6.5
Number of metastatic sites
 - 1 50 80.6
 - ≥  2 12 19.4
CA 19.9 (U/l)
 - Median (range) 1363 (0–328,209)
 - ≤  37 14 16.9
 - ≥  37 69 83.1